ArticleFrontiers in oncology2020

Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models.

Chun-Chieh Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.